Financial Statements/ESG Information - [Interim/Half-Year Report]

Research and development, clinical operations, manufacturing, regulatory communication, business development and commercialization of medical devices.

Interim Report 2025

Announcements and Notices - [Interim Results]

Clarification Announcement In Relation To
The Interim Results Announcement For
The Six Months Ended June 30, 2025

Interim Results Announcement
For The Six Months Ended June 30, 2025

Announcements and Notices - [Date of Board Meeting]

Date Of Board Meeting

Announcements and Notices - [List of Directors and their Role and Function]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Rainmed Medical (2297 HK)

Interim Report 2025

Clarification Announcement In Relation To The Interim Results Announcement For The Six Months Ended June 30, 2025

Interim Results Announcement For The Six Months Ended June 30, 2025

Date Of Board Meeting

List Of Directors And Their Roles And Functions

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)